[14] [15] Regular medication reviews typically every 36 months initially, then annuallyallow you and your healthcare team to reassess whether continuing GLP-1 therapy remains the best approach for your individual circumstances, based on both benefits and risks
GLP-1 receptor agonists were originally developed to treat diabetes, but they are being used more and more to help obese and overweight patients lose weight
Facebook Instagram TikTok Youtube About NBC Chicago Telemundo Chicago Our News Standards Submit Tips for Investigations Newsletters Connect With Us Xfinity: Internet, TV, streaming, more WMAQ Public Inspection File WMAQ Accessibility WMAQ Employment Information Send Feedback FCC Applications Terms of Service Your Privacy Choices Privacy Policy Advertise with us CA Notice Ad Choices Copyright 2026 NBCUniversal Media, LLC
When GHK-Cu peptides and vitamin C are used together in the same routine, their potent effects can be diminished
Excellent consultation with provider